KRAS and cancer: Combined analysis of n = 1079 human cancer cell lines (> 25 lineages) showed that activating mutations in KRAS, NRAS and HRAS correlate significantly with increased c-RAF gene dependency vs. wild-type RAS (Fig. S5A, C–E).